Sponsor & Developer Portfolio

University of Sao Paulo General Hospital

Clinical development pipeline, platform architecture, and registered trial tracking for University of Sao Paulo General Hospital vaccine candidates.

2
Candidates
2
Target Diseases
3
Linked Studies

Development Phase Distribution

Phase 3 Clinical Trial: 2

Platform Technologies

Biological (unspecified platform): 1 Protein / subunit: 1

Target Pathogens & Indications

Autoimmune Rheumatologic Disease Varicella / Zoster

Vaccine Pipeline Candidates (2)

Detailed candidate profiles, clinical phases, target indications, and anticipated milestones.

Phase 3 Clinical Trial ctgov-pneumococcal-vaccine-university-of-sao-paulo-general-hospital

Pneumococcal Vaccine

Target: Autoimmune Rheumatologic Disease

Platform: Biological (unspecified platform)

Key Milestone: Primary completion (most advanced trial): 2026-12-30 (registry estimate)
Phase 3 Clinical Trial ctgov-recombinant-zoster-vaccine-rzv-university-of-sao-paulo-general-h

Recombinant Zoster Vaccine (RZV)

Target: Varicella / Zoster

Platform: Protein / subunit

Key Milestone: Primary completion (most advanced trial): 2027-07-30 (registry estimate)

Explore Other Vaccine Developers & Sponsors

Compare pipeline volume, phase progression, and modalities across global biopharmaceutical manufacturers.

View All Vaccine Developers →